PROVETOP

Human HLA-A*02:01&B2M&TdT (ALYDKTKRI) Monomer Protein

Catalog No: TDT-HP001

Species
Human
Expression System
HEK293
Tag
His, Avi
Activity
Activity verified

Product overview

Recombinant Human HLA-A*02:01&B2M&TdT (ALYDKTKRI) Monomer Protein is expressed from HEK293 with His tag and Avi tag at the C-terminus. It contains Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and ALYDKTKRI peptide (accession: A0A140T913(HLA-A*02:01) & P61769(B2M) &ALYDKTKRI).

Product Details

Molecular Aliases
DNA nucleotidylexotransferase; terminal deoxynucleotidyl transferase
Protein Length
Gly25-Thr305
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 50.50 kDa. Due to glycosylation, the protein migrates to 52-65 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Supplied as 0.22 μm filtered solution in PBS (pH 7.4).
State
Liquid
Storage Conditions
Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Data Display

Bis-Tris PAGE
TDT-HP001 Bis-Tris-PAGE-white result

Human HLA-A*02:01&B2M&TdT (ALYDKTKRI) Monomer on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC
TDT-HP001 SEC-HPLC result

The purity of Human HLA-A*02:01&B2M&TdT (ALYDKTKRI) Monomer is greater than 95% as determined by SEC-HPLC.

ELISA
TDT-HP001 ELISA result

Immobilized Human HLA-A*02:01&B2M&TdT (ALYDKTKRI) Monomer, His Tag at 1μg/ml (100μl/well) on the plate. Dose response curve for Anti-B2M Antibody, mFc Tag with the EC50 of 11.3ng/ml determined by ELISA.

Background

The terminal deoxynucleotidyl transferase (TdT) belongs to the X family of DNA polymerases. This unusual polymerase catalyzes the template-independent addition of random nucleotides on 3'-overhangs during V(D)J recombination. The biological function and intrinsic biochemical properties of the TdT have spurred the development of numerous oligonucleotide-based tools and methods, especially if combined with modified nucleoside triphosphates.

References

  1. Sarac I, Hollenstein M. Terminal Deoxynucleotidyl Transferase in the Synthesis and Modification of Nucleic Acids. Chembiochem. 2019 Apr 1;20(7):860-871. doi: 10.1002/cbic.201800658. Epub 2019 Jan 25. PMID: 30451377.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support